Description: WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.
Home Page: www.wuxiapptec.com
288 Fute Zhong Road
Shanghai,
200131
China
Phone:
86 21 5046 1111
Officers
| Name | Title |
|---|---|
| Dr. Ge Li Ph.D. | Co-Founder, Chairman, President & CEO |
| Dr. Minzhang Chen Ph.D. | Co-CEO & Executive Director |
| Dr. Qing Yang Ph.D. | Co-CEO & Executive Director |
| Dr. Edward Hu M.B.A. | Vice Chairman, Global Chief Investment Officer, CEO of WuXi ATU & Head of DDSU |
| Ms. Ming Shi | Senior VP & CFO |
| Mr. Zhaohui Zhang | COO of China, Executive VP & Executive Director |
| Mr. Yuanzhou Zhang | Joint Company Secretary |
| Mr. Ruijia Tang | IR Director |
| Dr. Jingchao Dong Ph.D. | Senior VP & Head of RCS |
| Mr. Tao Guo Ph.D. | Senior VP and Head of RCS BD&IPM |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 13.245 |
|---|---|
| Trailing PE: | 19.2368 |
| Price-to-Book MRQ: | 2.7791 |
| Price-to-Sales TTM: | 0.5918 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 41116 |